Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment

S Sigala1, S Bodei, C Missale

  • 1Section of Pharmacology, Department of Biomedical Sciences and Biotechnology, University of Brescia Medical School, V.le Europa 11, 25123 Brescia, Italy. sigala@med.unibs.it

Insights

Nerve growth factor (NGF) impacts prostate cancer (PCa) cell malignancy. NGF treatment alters gene expression in PCa cells, potentially revealing new diagnostic and therapeutic targets for prostate cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Prostate cancer (PCa) progression is linked to dysregulated nerve growth factor (NGF) signaling.
  • NGF can reduce the malignancy of PCa cell lines by inducing p75(NGFR) expression.

Purpose of the Study:

  • To comprehensively analyze the gene expression profile regulated by NGF in the DU145 PCa cell line.
  • To identify specific genes and pathways influenced by NGF in prostate cancer cells.

Main Methods:

  • Utilized cDNA microarray technique to assess global gene expression changes.
  • Treated DU145 prostate cancer cell line with exogenous NGF.
  • Analyzed differential gene expression patterns.

Main Results:

  • NGF treatment decreased expression of 52 genes and increased expression of 40 genes in DU145 cells.
  • NGF modulated gene clusters associated with invasion, metastasis, proliferation, apoptosis, inflammation, metabolism, and transcription.
  • Observed a consistent pattern of gene modification across different PCa cell lines (DU145 and PC3).

Conclusions:

  • NGF significantly alters the molecular landscape of prostate cancer cells.
  • Identified NGF-regulated genes may serve as potential biomarkers for PCa progression.
  • Findings suggest novel avenues for developing diagnostic and therapeutic strategies for prostate cancer.

Related Concept Videos